ArticleBreast cancer (Dove Medical Press)2024

The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker.

Mehmet Emin Buyukbayram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.